scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10741-015-9515-6 |
P698 | PubMed publication ID | 26542377 |
P2093 | author name string | Sarita Gupta | |
Pawan K Singal | |||
Ashim K Bagchi | |||
Danielle da Silva Dias | |||
Nathalia Bernardes | |||
Gauri Akolkar | |||
Komal Rawal | |||
Tushar P Patel | |||
P2860 | cites work | Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 |
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction | Q24632414 | ||
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 | Q24679555 | ||
Free radicals in the physiological control of cell function | Q27860480 | ||
Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus | Q28190307 | ||
Oxidant stress and endothelial cell dysfunction | Q28609337 | ||
A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphory | Q28645870 | ||
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 | ||
Obesity induces a phenotypic switch in adipose tissue macrophage polarization | Q29547686 | ||
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes | Q29614548 | ||
Regulation of cardiac hypertrophy by intracellular signalling pathways | Q29615166 | ||
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage | Q29616101 | ||
Mitochondrial dysfunction and type 2 diabetes | Q29617913 | ||
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. | Q54062879 | ||
Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. | Q54101101 | ||
Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk | Q54116903 | ||
Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. | Q54610885 | ||
Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia | Q57607818 | ||
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management | Q58842177 | ||
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction | Q69973450 | ||
Perinatal hypothyroidism impairs the normal transition of GLUT4 and GLUT1 glucose transporters from fetal to neonatal levels in heart and brown adipose tissue. Evidence for tissue-specific regulation of GLUT4 expression by thyroid hormone | Q72272580 | ||
Treatment of hypertension in diabetes | Q72678727 | ||
Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications | Q72967716 | ||
Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production | Q73351602 | ||
Insulin resistance and cardiovascular disease | Q73397439 | ||
Microalbuminuria in Patients with Non-Insulin-dependent Diabetes Mellitus Relates to Nocturnal Systolic Blood Pressure | Q73498928 | ||
Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats | Q73515749 | ||
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease | Q73708513 | ||
Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study | Q74152600 | ||
Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects | Q74371090 | ||
Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis | Q77718606 | ||
Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat | Q80171660 | ||
Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis | Q80491559 | ||
Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia | Q80860389 | ||
Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A | Q95721179 | ||
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
Cellular mechanisms of insulin resistance | Q29619549 | ||
Mechanisms underlying endothelial dysfunction in diabetes mellitus | Q31829307 | ||
Endothelial dysfunction as a target for prevention of cardiovascular disease | Q33610670 | ||
Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy | Q33709276 | ||
Hypoglycemia, diabetes, and cardiovascular events | Q33873251 | ||
Mitochondrial DNA instability and peri-implantation lethality associated with targeted disruption of nuclear respiratory factor 1 in mice | Q33967022 | ||
Insulin resistance and cardiovascular disease | Q34011027 | ||
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance | Q34577169 | ||
Mechanisms linking obesity with cardiovascular disease | Q34590832 | ||
Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis | Q34881686 | ||
New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy | Q35115544 | ||
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function | Q35683727 | ||
Nuclear receptor signaling and cardiac energetics | Q35890852 | ||
Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. | Q35973475 | ||
Postprandial hyperglycemia and diabetes complications: is it time to treat? | Q35992276 | ||
Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance | Q36020413 | ||
Mechanisms of insulin resistance in humans and possible links with inflammation | Q36095510 | ||
Insulin resistance: a metabolic pathway to chronic liver disease | Q36297331 | ||
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph | Q36354637 | ||
Mitochondrial function, energy expenditure, aging and insulin resistance. | Q36369803 | ||
Adipose tissue biology and cardiomyopathy: translational implications | Q36496035 | ||
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system | Q36548154 | ||
High-fat diets cause insulin resistance despite an increase in muscle mitochondria | Q36693972 | ||
Oxidative stress in cardiovascular diseases and obesity: role of p66Shc and protein kinase C. | Q36763396 | ||
Signalling to translation: how signal transduction pathways control the protein synthetic machinery | Q36765810 | ||
Hypoglycemia and cardiovascular risks | Q36783714 | ||
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia | Q36916418 | ||
Leptin signaling and obesity: cardiovascular consequences | Q36943073 | ||
Role of mitochondrial dysfunction in insulin resistance | Q37097807 | ||
Insulin signalling in the heart | Q37129268 | ||
Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus | Q37350875 | ||
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance | Q37355863 | ||
Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. | Q37415343 | ||
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis | Q37526796 | ||
Skeletal muscle insulin resistance is the primary defect in type 2 diabetes | Q37624257 | ||
Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity. | Q37695058 | ||
Adaptive immunity in obesity and insulin resistance | Q38030832 | ||
Ectopic lipid storage and insulin resistance: a harmful relationship | Q38095619 | ||
Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory | Q38289787 | ||
Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells | Q38338004 | ||
Genes are differentially expressed in the epididymal fat of rats rendered obese by a high-fat diet | Q38358140 | ||
Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. | Q39567008 | ||
Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity | Q39800118 | ||
Macrophage-secreted factors induce adipocyte inflammation and insulin resistance | Q40326610 | ||
Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms | Q40511330 | ||
Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. | Q40758368 | ||
Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system | Q40933394 | ||
What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose | Q41411365 | ||
Potential role of TNFalpha and lipoprotein lipase as candidate genes for obesity | Q41581858 | ||
Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes | Q42098319 | ||
Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity | Q42455941 | ||
Adipocyte lipases and defect of lipolysis in human obesity | Q42485763 | ||
IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress | Q42801707 | ||
Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoter | Q42819714 | ||
Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase | Q42829211 | ||
Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in spontaneous hypertensive and Wistar-Kyoto rats | Q43434828 | ||
Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study | Q43643265 | ||
Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. | Q44489944 | ||
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study | Q44493428 | ||
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study | Q44495277 | ||
Adiponectin stimulates production of nitric oxide in vascular endothelial cells. | Q44565932 | ||
Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner | Q44730585 | ||
Role of diabetes in congestive heart failure: the Framingham study | Q44758886 | ||
Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus | Q45201529 | ||
Insulin hypersecretion: a distinctive feature between essential and secondary hypertension | Q45937499 | ||
Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia | Q46489681 | ||
Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension* | Q46796524 | ||
Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy | Q47647645 | ||
Cardiovascular Complications in Diabetics | Q47984014 | ||
Insulin resistance as an independent risk factor for carotid wall thickening. | Q51579378 | ||
Hyperinsulinemia as an independent risk factor for ischemic heart disease. | Q51581884 | ||
High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. | Q51628821 | ||
Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. | Q51653341 | ||
Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland | Q51662797 | ||
Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. | Q53890187 | ||
Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young | Q53937437 | ||
Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. | Q53970280 | ||
P433 | issue | 1 | |
P921 | main subject | cardiovascular disease | Q389735 |
type 2 diabetes | Q3025883 | ||
preproinsulin | Q7240673 | ||
insulin resistance | Q1053470 | ||
risk factor | Q1475848 | ||
P304 | page(s) | 11-23 | |
P577 | publication date | 2015-11-05 | |
P1433 | published in | Heart Failure Reviews | Q2167497 |
P1476 | title | Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes | |
P478 | volume | 21 |
Q90055054 | A Novel Antidiabetic Monomers Combination Alleviates Insulin Resistance Through Bacteria-Cometabolism-Inflammation Responses |
Q33879884 | A cross-sectional study on the associations of insulin resistance with sex hormone, abnormal lipid metabolism in T2DM and IGT patients |
Q89863602 | Aberrant expression of miR-214 is associated with obesity-induced insulin resistance as a biomarker and therapeutic |
Q55516148 | Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. |
Q39803045 | Agrimonia eupatoria L. and Cynara cardunculus L. Water Infusions: Comparison of Anti-Diabetic Activities. |
Q57488918 | An association of urinary sodium-potassium ratio with insulin resistance among Korean adults |
Q46301239 | Association of insulin resistance and autonomic tone in patients with pregnancy-induced hypertension |
Q59795787 | Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study |
Q90370734 | Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats |
Q38637752 | Cardiac transcriptome profiling of diabetic Akita mice using microarray and next generation sequencing |
Q60920170 | Cdc42: A Novel Regulator of Insulin Secretion and Diabetes-Associated Diseases |
Q91637063 | Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review |
Q46452587 | Diallyl trisulfide exerts cardioprotection against myocardial ischemia-reperfusion injury in diabetic state, role of AMPK-mediated AKT/GSK-3β/HIF-1α activation |
Q57289736 | Effect of Long-Term Exercise Training on lncRNAs Expression in the Vascular Injury of Insulin Resistance |
Q33858997 | Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study. |
Q92475946 | Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR) |
Q61814801 | Expression of Notch-1 and nuclear factor-κB signal pathway in myocardial cells of coronary heart disease rats |
Q38831748 | Heart selenoproteins status of metabolic syndrome-exposed pups: A potential target for attenuating cardiac damage |
Q96132942 | Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia |
Q93161720 | International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand |
Q40155189 | Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs |
Q93015863 | Loss of Glycine N-Methyltransferase Associates with Angiopoietin-Like Protein 8 Expression in High Fat-Diet-Fed Mice |
Q87789836 | Metabolic Syndrome Is Associated With Impaired Diastolic Function Independently of MRI-Derived Myocardial Extracellular Volume: The MESA Study |
Q92579507 | Nanoformulations of natural products for management of metabolic syndrome |
Q47548078 | Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population |
Q38845813 | Optimising the person-centred management of type 2 diabetes |
Q61813610 | Plant-Derived Oleanolic Acid (OA) Ameliorates Risk Factors of Cardiovascular Diseases in a Diet-Induced Pre-Diabetic Rat Model: Effects on Selected Cardiovascular Risk Factors |
Q97520357 | Potential roles of psychological and oxidative stress in insulin resistance: a cohort-based study |
Q47578175 | Prevalence of Metabolic Syndrome and Its Individual Components Among Midwestern University Students |
Q37078107 | Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan |
Q49962054 | Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort |
Q97520406 | Susceptibility to Hyperglycemia in Rats With Stress-Induced Depressive-Like Behavior: Involvement of IL-6 Mediated Glucose Homeostasis Signaling |
Q47107979 | Swimming training alleviated insulin resistance through Wnt3a/β-catenin signaling in type 2 diabetic rats |
Q42226832 | The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications |
Q91994816 | The Role of Protein Tyrosine Phosphatase (PTP)-1B in Cardiovascular Disease and Its Interplay with Insulin Resistance |
Q50179864 | The relationship between obesity and cognitive health and decline |
Q60948577 | Theaflavins Improve Insulin Sensitivity through Regulating Mitochondrial Biosynthesis in Palmitic Acid-Induced HepG2 Cells |
Q99551783 | Therapeutic effect of metformin in the treatment of endometrial cancer |
Q60044436 | To the editor regarding article "Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study" |
Q50099869 | miR-214-Dependent Increase of PHLPP2 Levels Mediates the Impairment of Insulin-Stimulated Akt Activation in Mouse Aortic Endothelial Cells Exposed to Methylglyoxal. |
Search more.